CQ37. Do Adjuvant Therapies Improve the Prognosis of Anaplastic Carcinoma in Patients Who Underwent Curative Surgery?

  • Kiminori Sugino
  • Naoyoshi Onoda


This CQ describes the necessity and effect of adjuvant therapies for anaplastic carcinoma curatively resected. However, no comparable studies between the existence and nonexistence of adjuvant therapies have been performed, and there are only reports of accumulated cases with long term survival.


Adjuvant Therapy External Beam Radiotherapy Curative Surgery Term Survival Weekly Paclitaxel 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Kebebew E, Greenspan FS, Clark OH et al (2005) Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer 103:1330–1335 (RS)PubMedCrossRefGoogle Scholar
  2. 2.
    Chen J, Tward JD, Shrieve DC et al (2008) Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma. Analysis of the surveillance, epidermiology, and end results 1983–2002. Am J Clin Oncol 31:460–464 (RS)PubMedCrossRefGoogle Scholar
  3. 3.
    Kim TY, Kim KW, Jung TS et al (2007) Prognostic factors for Korean patients with anaplastic thyroid carcinoma. Head Neck 29:765–772 (RS)PubMedCrossRefGoogle Scholar
  4. 4.
    Yau T, Lo CY, Epstein RJ et al (2008) Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy. Ann Surg Oncol 15:2500–2505 (RS)PubMedCrossRefGoogle Scholar
  5. 5.
    Chang HS, Nam KH, Chung WY et al (2005) Anaplastic thyroid carcinoma: a therapeutic dilemma. Yonsei Med J 46:759–764 (RS)PubMedCrossRefGoogle Scholar
  6. 6.
    De Crevoisier R, Baudin E, Bachelot A et al (2004) Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy. Int J Radiat Oncol Biol Phys 60:1137–1143 (PS)PubMedCrossRefGoogle Scholar
  7. 7.
    Pierie JP, Muzikansky A, Gaz RD et al (2002) The effect of surgery and radiotherapy on outcome of anaplastic thyroid carcinoma. Ann Surg Oncol 9:57–64 (RS)PubMedCrossRefGoogle Scholar
  8. 8.
    Haigh PI, Ituarte PH, Wu HS et al (2001) Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer 91:2335–2342 (RS)PubMedCrossRefGoogle Scholar
  9. 9.
    Voutilainen PE, Multanen M, Haapiainen RK et al (1999) Anaplastic thyroid carcinoma survival. World J Surg 23:975–979 (RS)PubMedCrossRefGoogle Scholar
  10. 10.
    Passler C, Scheuba C, Prager G et al (1999) Anaplastic (undifferentiated) thyroid carcinoma (ATC). A retrospective analysis. Langenbeck’s Arch Surg 384:284–293 (RS)CrossRefGoogle Scholar
  11. 11.
    Kobayashi T, Asakawa H, Umeshita K et al (1996) Treatment of 37 patients with anaplastic carcinoma of the thyroid. Head Neck 18:36–41 (RS)PubMedCrossRefGoogle Scholar
  12. 12.
    Junor EJ, Paul J, Reed NS (1992) Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy. Eur J Surg Oncol 18:83–88 (RS)PubMedGoogle Scholar
  13. 13.
    Ain KB, Egorin MJ, DeSimone PA (2000) Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Thyroid 10:587–594 (PS)PubMedCrossRefGoogle Scholar
  14. 14.
    Higashiyama T, Ito Y, Hirokawa M et al (2010) Induction chemotherapy with weekly paclitaxel administration for anaplastic thyroid carcinoma. Thyroid 20:7–14 (RS)PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 2013

Authors and Affiliations

  1. 1.Department of SurgeryIto HospitalTokyoJapan
  2. 2.Department of Surgical OncologyOsaka City University Graduate School of MedicineOsakaJapan

Personalised recommendations